11/26
07:05 am
okyo
OKYO Pharma to Participate at the 4th Annual BTIG Ophthalmology Conference [Yahoo! Finance]
Neutral
Report
OKYO Pharma to Participate at the 4th Annual BTIG Ophthalmology Conference [Yahoo! Finance]
11/26
07:00 am
okyo
OKYO Pharma to Participate at the 4th Annual BTIG Ophthalmology Conference
Neutral
Report
OKYO Pharma to Participate at the 4th Annual BTIG Ophthalmology Conference
11/15
09:09 am
okyo
MUSQ Global Music Industry ETF and OKYO Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV [Yahoo! Finance]
Low
Report
MUSQ Global Music Industry ETF and OKYO Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV [Yahoo! Finance]
11/15
09:00 am
okyo
MUSQ Global Music Industry ETF and OKYO Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Low
Report
MUSQ Global Music Industry ETF and OKYO Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
10/30
07:00 am
okyo
OKYO Pharma to Present at International Tear Film and Ocular Surface Society Conference
Low
Report
OKYO Pharma to Present at International Tear Film and Ocular Surface Society Conference
10/24
08:08 am
okyo
OKYO Pharma Limited (NASDAQ: OKYO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
Medium
Report
OKYO Pharma Limited (NASDAQ: OKYO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
10/23
07:00 am
okyo
OKYO Pharma Announces First Patient Dosed in the First Clinical Trial to Treat Neuropathic Corneal Pain
High
Report
OKYO Pharma Announces First Patient Dosed in the First Clinical Trial to Treat Neuropathic Corneal Pain
10/16
03:44 pm
okyo
OKYO Pharma Limited (NASDAQ: OKYO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
Low
Report
OKYO Pharma Limited (NASDAQ: OKYO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
10/16
07:00 am
okyo
OKYO Pharma Announces Start of Phase 2 Clinical Trial to Treat Patients with Neuropathic Corneal Pain
High
Report
OKYO Pharma Announces Start of Phase 2 Clinical Trial to Treat Patients with Neuropathic Corneal Pain